Shenzhen, China · Founded 2019 · Privately Held (backing)
Manufacturer of membrane protein drugs intended for neuropsychiatric disorders, chronic kidney disease and cardiovascular disease. CrystalO Biopharma is based in Shenzhen, China and was founded in 2019. It has raised $17.1 million.
Last price · $/share
—
Implied valuation
—
Total raised
$17.1M
Last round
—
Cap table — not yet on record
CrystalO Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CrystalO Biopharma with a free account
·Watch CrystalO Biopharma: the Monday email on marks, rounds and moves
